Edward Lang
Corporate Officer/Principal presso GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profilo
Edward Lang is currently the Chief Business Officer at Gyroscope Therapeutics Holdings Plc since 2019.
Prior to this, he was the Vice President-Corporate Affairs at Juno Therapeutics, Inc. from 2017 to 2018.
Mr. Lang completed his undergraduate degree at LaSalle University.
Posizioni attive di Edward Lang
Società | Posizione | Inizio |
---|---|---|
GYROSCOPE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 01/06/2019 |
Precedenti posizioni note di Edward Lang
Società | Posizione | Fine |
---|---|---|
JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/06/2018 |
Formazione di Edward Lang
LaSalle University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Edward Lang